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Abstract
As individuals seek increasingly individualised nutrition and lifestyle guidance, numerous apps and nutrition programmes have emerged.
However, complex individual variations in dietary behaviours, genotypes, gene expression and composition of themicrobiome are increasingly
recognised. Advances in digital tools and artificial intelligence can help individuals more easily track nutrient intakes and identify nutritional
gaps. However, the influence of these nutrients on health outcomes can vary widely among individuals depending upon life stage, genetics and
microbial composition. For example, folate may elicit favourable epigenetic effects on brain development during a critical developmental time
window of pregnancy. Genes affecting vitamin B12 metabolism may lead to cardiometabolic traits that play an essential role in the context of
obesity. Finally, an individual’s gut microbial composition can determine their response to dietary fibre interventions during weight loss. These
recent advances in understanding can lead to a more complete and integrated approach to promoting optimal health through personalised
nutrition, in clinical practice settings and for individuals in their daily lives. The purpose of this review is to summarise presentations made
during the DSM Science and Technology Award Symposium at the 13th European Nutrition Conference, which focused on personalised nutri-
tion and novel technologies for health in the modern world.
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Although most dietary recommendations today are based on
population averages, it is now possible to identify population
sub-groups, and even individuals, who may benefit from modi-
fied nutrition guidance. As technology continues to advance, it is
becoming easier for individuals to determine when they may be
at increased risk for disease or a nutritional deficiency. They can
access commercially available tools that provide precise guid-
ance relevant to their genetics, phenotype and preferences(1).
However, personalised nutrition approaches, such as consumer
nutrigenetics testing, have come under scrutiny(2). Such systems
require robust scientific substantiation, as recently described in a
set of guiding principles(3) and outlined by the Academy of
Nutrition and Dietetics for application to dietetic practice(4).
Over the past several decades, it has become increasingly clear
that a complex set of interactions exist among the genetic and
environmental variables affecting individual responses to diet
and lifestyle behaviours. Since the early 1990s, candidate gene
studies have identified several genetic variations which have
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led to the understanding of the pathophysiological mechanisms
and pathways that underlie complex diseases(5). In the last
15 years, significant advances have been made through
genome-wide association studies, with the discovery of several
novel loci for complex traits(6). However, these studies have
shown that only a small amount of individual variability can
be explained by genetics alone(7). More recently, a holistic view
has emerged regarding the interaction of genetics and other indi-
vidual factors(8). Such interactions can be behavioural, like the
relationships between individuals and their food preferences
and dietary intake, or physiological, such as genotype or
microbiome. These interactions, and the underlying individual
variations that drive them, play a significant role in personal
health and well-being over time. However, they also challenge
our existing approaches to research and complicate the applica-
tion of research findings for the development of personalised
nutrition guidance.
In this paper, we review four recent advances in the field of
personalised nutrition that can lead to an improved understand-
ing of individual health: (1) the influence of epigenetic changes
and gene expression on cognitive function in early life, (2) the
association genotype with nutrient status and corresponding
metabolic responses in the context of obesity, (3) the relation-
ship of gut microbial composition (enterotype) with the efficacy
of fibre-rich dietary interventions for body weight management
and (4) advanced technologies such as deep learning to improve
the accuracy of dietary intake measurements. By examining
these sources of inter-individual variability, and considering their
possible interactions, we can better understand the nuances
of individualised guidance and better define future research
approaches to advance both personal and public health.
Folate during pregnancy, epigenetic changes and child
health outcomes
Maternal nutrition during pregnancy is essential for optimal
offspring development, reducing lifelong disease burden and
optimising health throughout life(9). In particular, folate is
required for one-carbon metabolism, a network of metabolic
pathways involved in nucleotide synthesis, DNA repair and
numerous methylation reactions(10). In early pregnancy, there
is conclusive evidence that periconceptional folic acid supple-
mentation prevents neural tube defects(11,12). Maternal folate
supplementation may also affect neurocognitive development
in early life(13). This section focuses on the evidence linking
folate nutrition in pregnancy, DNA methylation changes and
health outcomes in the child.
Folate, DNA methylation and brain development during
pregnancy
Inadequate folate intake can interfere with early brain develop-
ment and function, the consequences of which can vary depend-
ing on the timing of the deficiency relative to the development of
the neurological structures(14). The third trimester of pregnancy
until 2 years after birth is a critical period of rapid growth and
development of some regions of the brain such as cortical and
subcortical grey matter(15). Therefore, the continuation of folic
acid supplementation beyond the first trimester (after the recom-
mended period for the prevention of neural tube defects)
may optimise folate status for prenatal brain development(14,16).
As such, maternal folate insufficiency appears to influence the
developing brain(17), which may result in lasting changes in child
brain function(13).
The effect of folate nutrition during pregnancy on health
outcomes in the child is thought to involve the essential role
of folate in one-carbon metabolism, which may impact
neurodevelopment(10,18). Folate-related epigenetic changes,
and specifically DNA methylation, have been proposed as a
plausiblemechanism underpinning associations betweenmater-
nal folate nutrition and various offspring health outcomes(19).
Epigenetic processes, including histone modifications, RNA
interference and DNA methylation, involve changes to the
genome that can alter gene expression without changing the
underlying DNA sequence(20). Early life development, ranging
from preconception to childhood, is considered to be a critical
window of the lifecycle, characterised by rapid DNAmethylation
changes, susceptibility to environmental factors and program-
ming of epigenetic marks that may have lasting health effects
in infants born to mothers with inadequate nutritional status(21).
Observational studies have reported that folic acid supple-
ment usage by women during pregnancy was associated with
changes in DNAmethylation patterns of candidate genes in cord
blood(22), with decreased methylation of LINE-1 and PEG3 and
increasedmethylation of IGF2 in cord blood(23) and offspring(24).
However, associations between maternal folate exposure and
the offspring methylome have been inconsistent(25).
The Folic Acid Supplementation in the Second and Third
Trimester (FASST) trial is thus far the only randomised trial of
folic acid supplementation in pregnancy examining DNA
methylation and maternal folate and homocysteine responses
and related effects in the newborn(26). In an analysis of bio-
banked samples from this trial, changes were found in DNA
methylation of LINE-1 and candidate genes related to brain
development such as IGF2 and BDNF, in the newborns of moth-
ers who received folic acid(27). Using an epigenome-wide
(EWAS) approach, changes in newborn DNA methylation at
the imprint regulator ZFP57 were also shown(28).
Cognitive performance in offspring related to folate
nutrition in pregnancy
Several observational studies have shown positive associations
between self-reported folic acid supplement use in early preg-
nancy and childhood neurodevelopmental outcomes such as
language delay, cognitive function score and verbal and motor
function(29–31). Likewise, clinical studies have reported reduced
cognitive ability in the offspring of mothers with suboptimal
folate status(32,33). Over 40 years ago, Gross et al.(34) showed that
children born to mothers with diagnosed folate-related megalo-
blastic anaemia in the third trimester of pregnancy had abnormal
neurodevelopment and lower intellectual abilities(34). Several
decades later, a longitudinal study of 256 mother–child pairs
linked maternal folate deficiency in later pregnancy with
reduced brain volume in the children aged 6–8 years, as mea-
sured using MRI(35). However, the evidence is inconsistent, as
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other observational studies have found no significant associa-
tions of folate status in pregnancywith cognitive performance(36)
or infant neurodevelopment(37).
The very few randomised trials conducted to date in this area
have investigated the effect of multiple micronutrient supple-
ments, not folate supplementation alone(13). The FASSTT
Offspring trial studied the effect of folic acid supplementation
during the 2nd and 3rd trimesters on the subsequent cognitive
performance of the child using validated assessment tools(38).
The children of folic acid-treated mothers scored significantly
higher than the placebo group in several cognitive domains at
3 and 7 years. When compared with nationally representative
samples of British children at 7 years, test scores were signifi-
cantly higher in children from folic acid-treated mothers for
Verbal IQ, Performance IQ, General Language and Full-Scale
IQ(38), suggesting a role for folate-mediated epigenetic changes
in genes related to brain development(27,28).
Whilst folate-mediated epigenetic changes in genes related to
brain development and function offer a biological basis to link
maternal folate with offspring cognitive effects, this area of
research is still in its infancy. Further carefully designed rando-
mised trials with validated cognitive tests and ideally incor-
porating objective brain imaging techniques are warranted.
Such studies could shed further light on the links between
folate nutrition during pregnancy and offspring health outcomes
and the underpinning epigenetic mechanisms. Personalised
approaches, such as accurate dietary assessment of folate intake,
or minimally invasive testing for folate status, are needed to
identify individuals at risk of folate insufficiency or deficiency.
More research is required in the case of 10 % of the worldwide
population who are homozygous for the methylenetetrahydro-
folate reductase C677T polymorphism as they have impaired
folate metabolism and may thus have higher dietary require-
ments for folate(39).
Genes affecting vitamin B12 metabolism and potential
role in cardiometabolic disease
Cardiometabolic diseases such as obesity, type 2 diabetes and
CVD are worldwide health problems and are now increasingly
prevalent(40). The role of vitamins in cardiometabolic disease risk
has more recently been the subject of research in this area.While
most of the research has concentrated on vitaminD(41), interest in
vitamin B12 as a modulator of metabolic disease risk has been
increasing(42).
Vitamin B12 deficiency and cardiometabolic diseases
The relationship between low plasma or serum vitamin B12 con-
centrations and cardiometabolic phenotypes could be the result
of several mechanisms(43). Vitamin B12 is a co-enzyme which
converts methylmalonyl-CoA to succinyl-CoA, a critical step in
the metabolism of odd-chain fatty acids. If this reaction cannot
occur, methylmalonyl-CoA levels elevate, inhibiting the rate-
limiting enzyme of fatty acid oxidation (carnitine palmitoyltrans-
ferase), leading to lipogenesis and insulin resistance(44). On the
other hand, reduced vitamin B12 concentrations in obese individ-
uals could result from a nutrient-poor diet and increased nutrient
requirements related to increased body size(45,46). Additionally,
deficiency of vitamin B12 can impair the remethylation of
homocysteine in the methionine cycle resulting in raised homo-
cysteine levels(47), which is associated with an increased risk
of CVD(48).
Although vitamin B12 deficiency is associated with a wide
range of chronic diseases and conditions, the relationship
between low vitamin B12 status and cardiometabolic-related
traits has remained inconsistent in numerous studies(42,49).
Polymorphisms in the key genes coding for proteins involved
in the absorption, cellular uptake and intracellular metabolism
of vitamin B12 may emerge as a feasible explanation for the
vitamin B12 variability observed within these studies(50).
Genetic studies have identified several genetic variants related
to vitamin B12 status, during the last few years(43). At present, only
three studies in European populations have investigated the
effect of genetically instrumented vitamin B12 concentrations
on cardiometabolic traits such as BMI(51), blood pressure(52)
and cardiometabolic risk(53), indicating the need to study more
diverse ethnic groups.
Vitamin B12 concentrations, which vary widely among
individuals, are responsive to changes in diet and are dependent
on the quality and consumption of animal protein(54). Therefore,
controlling diet is recommended in preventing vitamin B12
deficiency(55). As mentioned previously, deficiencies of vitamin
B12 and folate during pregnancy can affect DNA methylation(56),
suggesting that interactions between genes and nutrients may also
play a role in the development of cardiometabolic disease. Given
that the genetic make-up varies from individual to individual,
and there is variation in genetic heritage and food consumed
worldwide, it is vital to examine the interactive effects between
dietary factors and genetics on vitamin B12 concentrations and
metabolic traits (nutrigenetics)(57).
Gene–nutrient interactions with vitamin B12
Whilst only a few nutrigenetics studies have been carried
out in lower-middle-income countries, a large-scale collabora-
tive project called the ‘gene–nutrient interactions (GeNuIne)
Collaboration’ was established(57,58). One of the objectives of
the overall project was to investigate the effect of gene–nutrient
interactions on vitamin B12 concentrations and cardiometabolic
traits using population-based studies from various ethnic groups.
The first vitamin B12 pilot study of the GeNuIne Collaboration
was the Genetics of Obesity and Diabetes study. This
study explored the relationship of vitamin B12 status and
metabolic traits in 109 healthy Sinhalese adults in Colombo,
Sri Lanka(59). Genetic risk scores (GRS) were derived using ten
vitamin B12-associated SNP (B12-GRS).While there was a signifi-
cant association between the B12-GRS and B12 concentrations,
there was no significant impact of genetically instrumented B12
concentrations on any of the metabolic traits. However, there
was a significant interaction between the B12-GRS and protein
energy (%) on waist circumference, suggesting that a genetically
lowered vitamin B12 concentration may have an impact on
central obesity in the presence of lower dietary protein intakes.
The Minangkabau Indonesia Study is another nutrigenetic
study in South East Asians conducted in Indonesia as part of
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the GeNuIne Collaboration(60). The B12-GRS was constructed
based on nine vitamin B12 SNP, and a metabolic disease-related
GRS (metabolic-GRS) was developed based on nine metabolic
disease-related SNP. The study examined the relationship of
these risk scores with vitamin B12 levels and different metabolic
traits in 117 healthy Minangkabau Indonesian women. This
study demonstrated the impact of genetically instrumented B12
concentrations on HbA1C levels, a marker of glycaemic
control(61), through the influence of dietary fibre intake.
Given the increased prevalence of type 2 diabetes among
Asian Indians, the Chennai Urban Rural Epidemiology Study
from South India examined the association between two com-
monly studied fat mass and obesity-associated gene (FTO)
SNP on metabolic traits and vitamin B12 concentrations in 548
Asian Indians (GeNuIne Collaboration). The study identified
significant associations between the two FTO SNP not only
with a higher risk of obesity but also with a lower vitamin B12
concentration(62). These results suggest that increases in BMI
could potentially contribute to the adverse health effects associ-
ated with vitamin B12 deficiency. Amore recent study has shown
that long-term supplementation with vitamin B12 influences
the regulation of several type 2 diabetes-associated genes by
methylation of miRNA-coding gene, miR21, and could thus
epigenetically regulate the risk of obesity, insulin resistance
and type 2 diabetes(63).
While these findings are fascinating and highlight novel
possibilities of gene–nutrient interactions, they need to be
replicated in an independent cohort utilising a larger number
of samples. Further understanding of the role of these gene–diet
interactions at the molecular level is necessary before diets can
be personalised according to varying ethnicity or genotype.
Importance of microbial enterotypes in personalised
obesity management
As the prevalence of obesity has reached epidemic pro-
portions globally, the search for effective management
continues. Through multiple dietary intervention studies to
reduce energy content, it has become evident that there is con-
siderable weight loss variation among participants(64,65), indicat-
ing that no ‘one diet fits all’. Accordingly, dietary weight loss
success is likely dependent on several individual characteristics,
including host genetics and gut microbiota(66). While gut micro-
biota-modulating interventions can alleviate obesity in mice(67),
similar causal findings appear absent in human clinical trials.
However, this has also revealed the enormous variability of
the human gut microbiome within and across populations.
To reduce complexity, researchers have proposed stratifica-
tion of individuals according to distinct gut microbiota composi-
tion types termed ‘enterotypes’(68). Primarily two enterotypes
have consistently been found across populations; one type
dominated by Prevotella species, the other by Bacteroides
species(69). The establishment of these types seems to occur
during early childhood and to be highly influenced by long-term
dietary habits(70), with the Prevotella enterotype associated with
a carbohydrate- and fibre-rich diet. Conversely, the Bacteroides
enterotype is associated with a ‘Western diet’ low in fibre, and
high in fats and refined sugars(71). Factors such as age, sex, cul-
tural background and geography have been found to have little
influence on the establishment of enterotypes(69).
Enterotype predicts success in weight loss when
consuming high-fibre diets
Following the discovery of enterotypes, epidemiological studies
have found conflicting associations between enterotypes and
metabolic health(72,73). As the enterotypes seem to differ in their
ability to degrade dietary fibre(69), it is adjacent to speculate that
metabolic responses of the enterotypes depend on dietary com-
positions(74). Recent dietary intervention studies with healthy
European subjects point to a more beneficial role of a high-fibre
diet for individuals with a Prevotella enterotype than individuals
with the Bacteroides enterotype.
In 2015, Kovatcheva and co-workers convincingly linked
enterotypes to glucose metabolism after consuming a high-fibre,
barley-rich diet for 3 d(75). Specifically, they found that individ-
uals with the Prevotella enterotype improved their enzymatic
capacity for fibre degradation and glucosemetabolism as a result
of the diet, an effect not seen among Bacteroides enterotype
subjects.
Since then, Hjorth and co-workers reanalysed a 26-week ad
libitum study with a fibre-rich New Nordic Diet (NND) and an
average Danish diet, lower in fibre (43·3 v. 28·6 g/10 MJ), and
predicted dietary success based on pre-treatment faecal
Prevotella:Bacteroides (P:B) ratio(76). While the high P:B group
lost weight on NND compared with the control diet, the low
P:B group did not. Interestingly, during the 1-year follow-up
period, subjects with the high P:B ratio who changed from the
control diet to the recommended NND managed to maintain
their weight loss, whereas subjects with the low P:B ratio who
changed from the control diet to the NND regained weight.
To validate these findings, two other dietary intervention
studies aimed at weight loss were stratified by enterotype(77,78).
Similarly, these studies observed that subjects who consumed a
high-fibre diet for 6 months lost more weight if they had a high
P:B ratio v. a low P:B ratio. Furthermore, in a 6-week ad libitum
study comparing whole grains with refined wheat (fibre intake:
33 g/d v. 23 g/d), a 1·8 kg weight loss was observed among
participants with high Prevotella abundance, and no difference
in the low Prevotella group(79). The finding suggests that specific
whole-grain fibres, such as arabinoxylans, benefit the Prevotella
enterotype, likely due to a beneficial match between species
enzymatic degradation capacity of especially the prevalent
Prevotella species, P. copri(80). In comparison, the colonic
functional and ecological properties seem less uniform among
subjects with a Bacteroides enterotype(81).
Enterotypes at lower taxonomical levels and host
digestive capacity
Until recently, the majority of dietary intervention studies have
been limited to genus level taxonomy by 16S rRNA gene
sequencing. Although with continuous advances in the field
of sequencing, species-level taxonomy is now widespread,
revealing a large inter-individual variation in Bacteroides and
Prevotella species(74). Moreover, at the strain level, recent
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pioneering microbiome studies demonstrated that P. copri is not
a monotypic species, but encompasses four distinct clades with
substantial functional diversity differences including the ability
to degrade whole-grain fibres(82). Consequently, if weight loss
is affected by the colonic bacterial enzymatic capacity, future
enterotype studies need deep-level sequencing to explain
potential weight loss variability further.
Another intriguing factor in obesity management is the ability
of the host to degrade the major polysaccharide component of
diets, starch(83). If dietary starches escape host digestion in the
small intestine, it will primarily feed Prevotella and Bacteroides
species located distally in the gut. Amylase secreted from the
salivary glands and pancreas determines the amount of starch
escaping host digestion, and genetically the salivary amylase
gene (AMY-1) exhibits some of the greatest copy numbers
(CN) of any human gene(84). Stratification of participants of the
26-week NND study (discussed above) according to AMY-1
CN (i.e. low and high AMY-1 CN groups, respectively) further
explained weight loss variability(85). Here, the majority of weight
loss difference between enterotypes was observed in the low
AMY-1 CN group with a strong linear relationship between
P:B ratio and weight loss, which was not found for the high
AMY-1 CN group. This indicates that not only dietary fibre but
also the total pool of fermentable substrate reaching the colon
play a role in theweight loss difference between the enterotypes.
Moving this field forward, there is furthermore a need to
understand the underlying mechanisms linking microbial
fibre fermentation to host metabolic alterations. To elucidate this,
microbial metabolites produced in the colon that enter circula-
tion and interact with host cells need to be investigated
(e.g. SCFA)(86). In conclusion, microbial enterotypes are cur-
rently highly interesting biomarkers for explaining variability
in weight loss upon intake of dietary fibre and whole-grain-rich
diets(87). Soon, it might be possible to complement personalised
dietary weight-loss strategies with microbial enterotype tests,
thus ensuring dietary preferences of both the individual and
the colonic microbes. Such a personalised approachmay, in fact,
support dietary adherence and long-term weight maintenance.
Advanced technologies for food image recognition
in nutrient intake assessment
Dietary assessment is a crucial step in the real-world deployment
of any personalised nutrition programme. The ability of an indi-
vidual to track their food intake plays a role in self-monitoring as
a critical aspect of behaviour change(88). It can also provide
a professional dietitian with information on how a client is
adhering to their individualised meal plan. However, assessing
dietary intakewith traditionalmethods carries considerable costs
and burden to the individual. Such methods are also prone to
errors as they often rely on self-reporting(89).
Advanced solutions are needed to objectively quantify food
and beverage intake(90). Food image recognition is a promising
strategy because most individuals own a smartphone with a
camera, so the barrier to entry is low, and it can reach a large
population. However, automatically recognising food items
from images is a challenging computer vision problem due to
a variety of issues: (1) foods are typically deformable objects,
(2) foods can lose their visual information during preparation,
(3) different foods can appear visually similar, (4) the same
food can appear differently depending on the lighting or angle
and (5) limited amount of visual information for beverages(91).
Only after foods are visually recognised, can they be reliably
linked to a food composition database(92).
The introduction of the Pittsburgh Fast-Food ImageDataset in
2009 facilitated early research in this area based on manual rec-
ognition methods, but these approaches mostly achieved only
10–40 % classification accuracy(93,94). In 2014, deep learning
was first used to recognise food images. Deep learning, or deep
neural networks, allows computational models composed of
multiple processing layers to learn relevant image features
through training on a set of input images(95,96). Deep convolu-
tional neural networks are inspired by the visual system of ani-
mals, where individual neurons assess the visual input by
reacting to overlapping regions in the visual field(97). Because
they can classify each pixel of the image, they can recognise
any number of items, along with their location and size, allowing
for food volume and food weight estimation. This approach
has achieved substantially better results than other methods,
resulting in an increased focus on deep learning in recent
research(98,99).
A novel deep learning architecture for food image recogni-
tion, called NutriNet, has been developed by Mezgec and
Koroušić Seljak(91). It is a modification of the well-known
AlexNet architecture(100), with increased image size and an
additional convolutional layer at the beginning of the neural
network(91). NutriNet was first trained on 225 953 freely available
images that were downloaded from the Internet and organised
into appropriate food classes (520 unique food items). When
tested against three popular deep learning architectures of the
time (AlexNet(100), GoogLeNet(101) and ResNet(102)), NutriNet
was found to be superior to AlexNet and GoogLeNet and faster
to train than all three of the other architectures. The deep learn-
ing approach was then used to recognise any number of items
in a single food image using a training set obtained from the
‘fake food buffet’(103), which is visually similar to real food.
Fully convolutional networks, introduced by Long et al.(104),
were applied to perform semantic segmentation, partitioning
the image into logical parts and classifying each part on a pixel
level. Due to the complexity of food images, an fully convolu-
tional network variant that can segment images at the finest grain
(fully convolutional network-8s)(104) was used to train a model
on the fake food buffet image data set. Output predictions of
the trained model were compared with the ground-truth labels
using the pixel accuracy measure(104), and the final accuracy
of the trained fully convolutional network-8smodel was 92·18 %.
In recent years, deep learning has been validated numerous
times as a suitable solution for recognising food images(98).
Availability of food image data sets has been improving(105–107),
although there is a need for validation against data sets fromdiffer-
ent regions across the world. Futureworkwill focus on real-world
food images, which exhibit more variance compared with the test
images used in the research environment. In the future, such
technology could be used to improve dietary assessment in clini-
cal trials. For example, it can play a role in human studies in the
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areas mentioned above, where accurate quantification of folate,
vitamin B12 and energetic intake is critical. Consumer wellness
apps can also apply this solution in the future, improving the
dietary assessment of individuals and facilitating self-monitoring
towards positive behaviour change.
Looking towards the future: considerations to facilitate
individualised nutrition guidance
From the four examples discussed here, it is clear that scientific
evidence about individualised responses to nutrient intakes
continues to emerge. By recognising these sources of individual
variation, we have the potential to improve the conduct and
interpretation of clinical trials. For example, in studies of folate
status and epigenetics, dietary intake assessment may be
enhanced by the use of an advanced technique such as the
one described here. In obesity research, understanding genes
related to salivary amylase and vitamin B12 metabolism, and
gut microbiota composition, may enable better prediction of
responders and non-responders and dietary adherence to an
intervention could be assessed by photo recognition.
Such approaches can also play a role in the development of
personalised nutrition programmes in the public health arena.
For maternal health, such an app could help to identify women
at risk of folate deficiency, providing themwith guidance on how
to identify foods with adequate folate, or supplementation
options that meet their individual preferences. Aweightmanage-
ment app could integrate automated dietary intake assessment
with information on genotype and microbiome composition to
provide a user with more pertinent and individualised guidance.
As new information comes to light, such as that described in
the four examples in this paper, confidence in individualised
nutrition guidance is likely to increase. In the meantime, compa-
nies and organisations developing personalised nutrition
programmes must take science-based, ethical and rigorous
approaches in developing their guidance(3,108). In this way, per-
sonalised nutrition approaches can maintain their credibility,
provide maximum benefit to the individual and advance public
health.
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